376 related articles for article (PubMed ID: 31761247)
1. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic 5-fluorouracil prodrug encapsulated xylan-stearic acid conjugates nanoparticles for colon cancer therapy.
Sauraj ; Kumar V; Kumar B; Deeba F; Bano S; Kulshreshtha A; Gopinath P; Negi YS
Int J Biol Macromol; 2019 May; 128():204-213. PubMed ID: 30684574
[TBL] [Abstract][Full Text] [Related]
3. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy.
Sauraj ; Kumar SU; Kumar V; Priyadarshi R; Gopinath P; Negi YS
Carbohydr Polym; 2018 May; 188():252-259. PubMed ID: 29525163
[TBL] [Abstract][Full Text] [Related]
4. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.
Zhang Y; Yang C; Wang W; Liu J; Liu Q; Huang F; Chu L; Gao H; Li C; Kong D; Liu Q; Liu J
Sci Rep; 2016 Feb; 6():21225. PubMed ID: 26876480
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
7. Tunable pH and redox-responsive drug release from curcumin conjugated γ-polyglutamic acid nanoparticles in cancer microenvironment.
Pillarisetti S; Maya S; Sathianarayanan S; Jayakumar R
Colloids Surf B Biointerfaces; 2017 Nov; 159():809-819. PubMed ID: 28886517
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z
Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
10. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
11. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
12. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
13. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
[TBL] [Abstract][Full Text] [Related]
14. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
[TBL] [Abstract][Full Text] [Related]
15. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Effect of Self-Assembled Curcumin and Piperine Co-Loaded Human Serum Albumin Nanoparticles on Suppressing Cancer Cells.
Abolhassani H; Safavi MS; Handali S; Nosrati M; Shojaosadati SA
Drug Dev Ind Pharm; 2020 Oct; 46(10):1647-1655. PubMed ID: 32892656
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
18. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
19. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive nanoparticles based on xylan-lipoic acid conjugate for tumor targeted drug delivery of niclosamide in cancer therapy.
Sauraj ; Kumar A; Kumar B; Kulshreshtha A; Negi YS
Carbohydr Res; 2021 Jan; 499():108222. PubMed ID: 33401229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
